Accepting new patients.

Peptide therapy · Immune support

LL-37 in Jacksonville, FL.

At Healing Advanced Solutions in Jacksonville, FL, LL-37 starts with a free consultation, and Catherine Seidle, APRN decides fit, dose, and monitoring against your history. LL-37 is a peptide the human body makes as part of its innate immune defense.

  • Provider-prescribed
  • COA-verified lots
  • Traceable sourcing

FDA status. Peptides dispensed here are not FDA-approved drug products, and the FDA has not evaluated them for safety or effectiveness. LL-37 is prescribed only after a provider reviews your history.

What is LL-37?

LL-37 is a 37 amino acid peptide the human body makes as part of its first-line immune defense. Immune cells release it, and so do the cells lining the skin, gut, and airways when they meet a threat. Vitamin D increases the body's own production of it. Here it is prescribed after a free consultation and a review of your history.

LL-37 peptide injection vial for slow-healing wounds, shown as an illustrated take-home vial with the HAS label

LL-37 benefits and uses.

  • Slow-healing wounds

    The top use studied in people. A small randomized trial of topical LL-37 in venous leg ulcers reported faster healing at lower concentrations.

  • Immune defense

    In the lab, LL-37 disrupts bacterial membranes and draws immune cells toward infection.

  • Skin barrier

    Lab work describes how LL-37 acts in the skin's own defense and repair.

  • 37amino acids, made by your own immune cells
  • 34people in its first-in-human wound trial

How does LL-37 work?

LL-37 acts directly on microbes, disrupting bacterial membranes. It also signals to the immune system, drawing immune cells toward infection or injury and influencing how the skin barrier repairs. In wound healing studies, the interest has been in whether adding LL-37 to a slow-healing wound speeds the repair the body is struggling to complete.

What does the research on LL-37 show?

  • Human study

    In a first-in-human randomized trial of 34 people with venous leg ulcers, topical LL-37 reported faster healing at lower concentrations. Gronberg 2014

  • Human study

    A randomized trial studied an LL-37 cream in diabetic foot ulcers. Miranda 2023

  • Human study

    A human study looked at LL-37 taken by mouth. Zhao 2023

  • Lab study

    Lab work describes how LL-37 acts in the skin. Nakatsuji 2017

LL-37 side effects and safety.

  • Human safety data are for topical or oral use over short periods; there is none for injection.
  • FDA states that nonclinical findings suggest harmful effects on male reproduction and that LL-37 can promote tumor growth in some tissues.
  • In its first human trial, the response did not increase with dose.

Because of FDA's safety statements, LL-37 is prescribed only after Catherine Seidle, APRN reviews your history, including any personal or family history of cancer and any plans to have children.

Starting LL-37 in Jacksonville.

  1. Free consultation

    Ten to fifteen minutes by phone or video about what you want LL-37 for.

  2. Your visit

    Catherine Seidle, APRN reviews your history, and labs where they are needed.

  3. Your take-home vial

    Prescribed and dispensed with bacteriostatic water and syringes, ready to use at home.

  4. Follow-up

    Your dose and schedule are adjusted to how you respond.

  • No gray-market or research-chemical vials
  • A certificate of analysis with every vial
  • Prescribed by a licensed provider

Common questions.

What is LL-37?

LL-37 is a peptide your body makes as part of its first-line immune defense, released by immune cells and the cells lining the skin, gut, and airways.

What does LL-37 do?

It disrupts bacterial membranes and draws immune cells toward infection in lab studies. In people, topical LL-37 has been studied for slow-healing wounds.

Is LL-37 safe?

Human data are for topical and oral use over short periods. FDA states that nonclinical findings suggest harm to male reproduction and that it can promote tumor growth in some tissues, which is why your history is reviewed first.

Is LL-37 FDA approved?

No. It has never been approved, and its nomination for the compounding list was withdrawn.

How is LL-37 taken?

How it is given and on what schedule is set by Catherine Seidle, APRN at your visit.

How much does LL-37 cost?

A take-home vial is $240. The consultation is free, and any visit or labs your plan needs are quoted before you start.

How is LL-37 related to vitamin D?

Vitamin D increases the body's own production of LL-37, one of the links between vitamin D status and infection resistance.

Text us about peptide therapy

This information is for general education and is not medical advice, a diagnosis, or a substitute for care from your provider.

Catherine Seidle, APRN, functional and integrative medicine nurse practitioner at Healing Advanced Solutions in Jacksonville, FL
Your first visit is with Catherine Seidle, APRN.

Tell us the goal. Get a real answer.

Ten to fifteen minutes with our team. Tell us why LL-37 is on your radar, and we will help you decide whether it fits, and what the evidence actually supports.

We reply within one business day.

Book a free consultation.

A free 10 to 15 minute call, by phone or video. No cost, no obligation.

Kept confidential, never sold or shared. This form is not covered by the HIPAA Privacy Rule, so please leave out sensitive medical details.

We reach out to schedule, usually by the next business day.

4.9 from 54 reviews Catherine Seidle, APRN